Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Cancer × Cisplatin × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 126 Head and Neck Neoplasms 54 Squamous Cell Carcinoma of Head and Neck 52 Lung Neoplasms 45 Stomach Neoplasms 41 Esophageal Neoplasms 31 Urinary Bladder Neoplasms 27 Neoplasms 26 Uterine Cervical Neoplasms 24 Carcinoma, Squamous Cell 23 Parkinson Disease 4, Autosomal Dominant Lewy Body 22 Neoplasm Metastasis 20 Small Cell Lung Carcinoma 19 Breast Neoplasms 17 Cholangiocarcinoma 16 Carcinoma 14 Mesothelioma, Malignant 12 Adenocarcinoma Of Esophagus 12 Triple Negative Breast Neoplasms 11 Ovarian Neoplasms 11 Pancreatic Neoplasms 10 Biliary Tract Neoplasms 10 Adenocarcinoma 10 Mesothelioma 9 Gallbladder Neoplasms 9 Fallopian Tube Neoplasms 9 Oropharyngeal Neoplasms 8 Esophageal Squamous Cell Carcinoma 8 Carcinoma, Transitional Cell 8 Carcinoma, Ovarian Epithelial 7

Interventions

Nivolumab 6 linrodostat 3 relatlimab 2 Pemetrexed 2 Ipilimumab 2 tislelizumab 1 regorafenib 1 ralimetinib 1 p38 Mitogen-Activated Protein Kinases 1 efatutazone 1 abemaciclib 1 Vorinostat 1 Tamoxifen 1 Ranitidine 1 Midazolam 1 LY2603618 1 LY2584702 1 Gemcitabine 1 Fulvestrant 1 Dasatinib 1 Crizotinib 1 Cetuximab 1 Carboplatin 1 BMS-813160 1 3-(9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡